Following a meeting of the executive steering group earlier this month, PharmaTimes Media has been busily contacting each and every entrant to the highly prestigious Clinical Researcher of the Year – The Americas competition to reveal their fate.
29th March 2018
The Awards Ceremony, to be held at the Millennium Gloucester Hotel in London’s Kensington on 17 May, is a must-attend event for anyone in the pharma industry.
29th March 2018
PharmaTimes Communications Team of the Year has a long history of being the only pharma industry award that tests the competencies and potential of communications agency teams, benchmarking talent agency side. Such is the popularity of the competition that the decision has been taken to increase the number of categories and with it, the opportunity for agencies – and individuals - to shine.
29th March 2018
Some patients receiving chemotherapy after surgery for bowel cancer might only need three months of treatment rather than the six months currently given, according to new research published in Lancet Oncology.
29th March 2018
EU regulators have validated Shire’s application to market its experimental hereditary angioedema (HAE) drug lanadelumab, indicating that there is sufficient data to begin a priority review.
29th March 2018
The European Medicines Agency has accepted for review Sanofi's experimental type I diabetes therapy sotagliflozi.
29th March 2018
Takeda has revealed that it is considering making a move on Shire to add ballast to its core therapeutic areas.
29th March 2018
Designed to assess and reward the competencies and potential of pharma marketers and aspiring marketers, the prestigious PharmaTimes Marketer of the Year competition identifies and benchmarks marketing talent within pharma organisations, against the wider industry. The competition, which this year celebrates its 25th anniversary is now open for entry and marketers at all levels of their career are invited to enter.
28th March 2018
NHS England and NHS Improvement have revealed their intention to work much more closely together to maximise efficiencies and reduce duplication.
28th March 2018
Ipsen’s Cometriq can now be routinely funded by the NHS to treat patients with medullary thyroid cancer (MTC) in England and Wales.
28th March 2018
The House of Lords EU Committee is urging the government to clarify the reciprocal healthcare arrangements for UK citizens in the EU and EU citizens in the UK post Brexit.
28th March 2018
Six medicines have taken a big step towards European approval having been recommended by the European Medicines Agency’s Committee for Medicinal Products for Human Use.
28th March 2018
Prime Minister Theresa May has voiced support for a new long-term funding plan for the National Health Service, while the DH has unveiled a capital investment of £760 million to improve buildings and services.
28th March 2018
The financial position of the NHS remains in a perilous state, largely because of the continued focus on short-term fixes, concludes a new report by the Public Accounts Committee (PAC).
27th March 2018
Hospitals across the UK are failing to test all bowel cancer patients at the time of their diagnosis for a genetic condition called Lynch syndrome, which significantly increases the risk of developing cancer over a lifetime.
27th March 2018
